• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves.新霉素可防止生物人工心脏瓣膜中酶介导的糖胺聚糖降解。
Biomaterials. 2007 Jun;28(18):2861-8. doi: 10.1016/j.biomaterials.2007.02.017. Epub 2007 Mar 13.
2
Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.猪主动脉心脏瓣膜中的糖胺聚糖降解酶:对生物人工心脏瓣膜退变的影响
J Heart Valve Dis. 2003 Mar;12(2):217-25.
3
Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves.新霉素增强戊二醛交联生物瓣的细胞外基质稳定性。
J Biomed Mater Res B Appl Biomater. 2011 Nov;99(2):217-29. doi: 10.1002/jbm.b.31889. Epub 2011 Jun 28.
4
The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves.糖胺聚糖稳定化对生物人工心脏瓣膜组织屈曲的影响。
Biomaterials. 2008 Apr;29(11):1645-53. doi: 10.1016/j.biomaterials.2007.12.009. Epub 2008 Jan 15.
5
Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage.在体外循环疲劳和储存过程中,新霉素结合可保护生物人工心脏瓣膜中的细胞外基质。
Acta Biomater. 2009 May;5(4):983-92. doi: 10.1016/j.actbio.2008.11.004. Epub 2008 Nov 27.
6
Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization.靶向糖胺聚糖的固定以改善生物人工心脏瓣膜的稳定性。
Biomaterials. 2007 Jan;28(3):496-503. doi: 10.1016/j.biomaterials.2006.09.005. Epub 2006 Oct 9.
7
Enzyme-oxidative-polymerization method for improving glycosaminoglycans stability and reducing calcification in bioprosthetic heart valves.酶氧化聚合方法提高生物心脏瓣膜中糖胺聚糖的稳定性和减少钙化。
Biomed Mater. 2019 Feb 8;14(2):025012. doi: 10.1088/1748-605X/aafd7c.
8
Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves.新霉素固定后乙醇预处理可减少生物瓣的皱缩和钙化。
J Biomed Mater Res B Appl Biomater. 2010 Jan;92(1):168-77. doi: 10.1002/jbm.b.31503.
9
Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves.采用新霉素和碳二亚胺交联代替戊二醛以提高生物心脏瓣膜的耐久性。
J Biomater Appl. 2013 May;27(8):948-60. doi: 10.1177/0885328211430542. Epub 2011 Dec 29.
10
Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves.猪生物人工心脏瓣膜中糖胺聚糖的稳定性与功能
Biomaterials. 2006 Mar;27(8):1507-18. doi: 10.1016/j.biomaterials.2005.08.003. Epub 2005 Sep 6.

引用本文的文献

1
Butterfly-Inspired Multiple Cross-Linked Dopamine-Metal-Phenol Bioprosthetic Valves with Enhanced Endothelialization and Anticalcification.受蝴蝶启发的多交联多巴胺-金属-酚基生物假体瓣膜,具有增强的内皮化和抗钙化性能。
ACS Appl Mater Interfaces. 2024 Nov 27;16(47):64522-64535. doi: 10.1021/acsami.4c14256. Epub 2024 Nov 13.
2
The tensile and viscoelastic properties of aortic valve leaflets treated with a hyaluronidase gradient.用透明质酸酶梯度处理的主动脉瓣小叶的拉伸和粘弹性特性。
Cardiovasc Eng Technol. 2013 Jun;4(2):151-160. doi: 10.1007/s13239-013-0122-1. Epub 2013 Jan 24.
3
Biomimetic proteoglycans as a tool to engineer the structure and mechanics of porcine bioprosthetic heart valves.仿生蛋白聚糖作为一种工具,可用于构建和调控猪生物心脏瓣膜的结构和力学性能。
J Biomed Mater Res B Appl Biomater. 2024 Jan;112(1):e35336. doi: 10.1002/jbm.b.35336. Epub 2023 Oct 11.
4
Preservation of Mechanical and Morphological Properties of Porcine Cardiac Outflow Vessels after Decellularization and Wet Storage.去细胞化及湿储存后猪心脏流出道血管的力学和形态学特性保存
Biomimetics (Basel). 2023 Jul 17;8(3):315. doi: 10.3390/biomimetics8030315.
5
Acellular Vascular Scaffolds Preloaded With Heparin and Hepatocyte Growth Factor for Small-Diameter Vascular Grafts Might Inhibit Intimal Hyperplasia.肝素和肝细胞生长因子预载去细胞血管支架用于小直径血管移植物可能抑制内膜增生。
Cell Transplant. 2022 Jan-Dec;31:9636897221134541. doi: 10.1177/09636897221134541.
6
The hybrid crosslinking method improved the stability and anti-calcification properties of the bioprosthetic heart valves.混合交联方法提高了生物人工心脏瓣膜的稳定性和抗钙化性能。
Front Bioeng Biotechnol. 2022 Sep 9;10:1008664. doi: 10.3389/fbioe.2022.1008664. eCollection 2022.
7
Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.生物人工心脏瓣膜钙化的机制与药物治疗
Front Pharmacol. 2022 Jun 3;13:909801. doi: 10.3389/fphar.2022.909801. eCollection 2022.
8
Exogenous hyaluronic acid and chondroitin sulfate crosslinking treatment for increasing the amount and stability of glycosaminoglycans in bioprosthetic heart valves.外源性透明质酸和硫酸软骨素交联处理增加生物瓣心脏瓣膜中糖胺聚糖的含量和稳定性。
J Mater Sci Mater Med. 2019 Mar 6;30(3):38. doi: 10.1007/s10856-019-6237-7.
9
A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials.一种用于提高基于组织的生物材料的抗撕裂性和生物相容性的新型交联方法。
Biomaterials. 2015 Oct;66:83-91. doi: 10.1016/j.biomaterials.2015.07.011. Epub 2015 Jul 14.
10
Partnership for sustainability in cardiac surgery to address critical rheumatic heart disease in sub-Saharan Africa: the experience from Rwanda.撒哈拉以南非洲地区心脏外科手术可持续发展伙伴关系应对严重风湿性心脏病:卢旺达的经验
World J Surg. 2014 Sep;38(9):2205-11. doi: 10.1007/s00268-014-2559-2.

本文引用的文献

1
Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization.靶向糖胺聚糖的固定以改善生物人工心脏瓣膜的稳定性。
Biomaterials. 2007 Jan;28(3):496-503. doi: 10.1016/j.biomaterials.2006.09.005. Epub 2006 Oct 9.
2
A colorimetric method for the determination of glucosamine and chondrosamine.一种用于测定氨基葡萄糖和软骨糖胺的比色法。
Biochem J. 1933;27(6):1824-8. doi: 10.1042/bj0271824.
3
Extracellular matrix changes in knee joint cartilage following bone-active drug treatment.骨活性药物治疗后膝关节软骨的细胞外基质变化
Cell Tissue Res. 2006 May;324(2):279-89. doi: 10.1007/s00441-005-0131-y. Epub 2006 Jan 28.
4
Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves.猪生物人工心脏瓣膜中糖胺聚糖的稳定性与功能
Biomaterials. 2006 Mar;27(8):1507-18. doi: 10.1016/j.biomaterials.2005.08.003. Epub 2005 Sep 6.
5
Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiae.硫酸化寡糖作为牛睾丸、蜂毒和无乳链球菌透明质酸酶的抑制剂
Planta Med. 2005 Aug;71(8):727-32. doi: 10.1055/s-2005-871255.
6
Calcification of tissue heart valve substitutes: progress toward understanding and prevention.组织心脏瓣膜替代品的钙化:在理解和预防方面的进展
Ann Thorac Surg. 2005 Mar;79(3):1072-80. doi: 10.1016/j.athoracsur.2004.06.033.
7
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.生物人工心脏瓣膜钙化的预防:挑战与展望。
Expert Opin Biol Ther. 2004 Dec;4(12):1971-85. doi: 10.1517/14712598.4.12.1971.
8
Hyaluronic acid grafting mitigates calcification of glutaraldehyde-fixed bovine pericardium.透明质酸接枝可减轻戊二醛固定牛心包的钙化。
J Biomed Mater Res A. 2004 Aug 1;70(2):328-34. doi: 10.1002/jbm.a.30088.
9
Reduced calcification of bioprostheses, cross-linked via an improved carbodiimide based method.通过改进的基于碳二亚胺的方法交联的生物假体钙化减少。
Biomaterials. 2004 Nov;25(24):5523-30. doi: 10.1016/j.biomaterials.2003.12.054.
10
Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves.细胞外基质降解酶在猪无支架主动脉生物人工心脏瓣膜中具有活性。
J Biomed Mater Res A. 2003 Sep 15;66(4):755-63. doi: 10.1002/jbm.a.10066.

新霉素可防止生物人工心脏瓣膜中酶介导的糖胺聚糖降解。

Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves.

作者信息

Raghavan Devanathan, Simionescu Dan T, Vyavahare Naren R

机构信息

Cardiovascular Implant Research Laboratory (CIRL), Department of Bioengineering, Clemson University, 401 Rhodes Engineering Center, Clemson, SC 29634, USA.

出版信息

Biomaterials. 2007 Jun;28(18):2861-8. doi: 10.1016/j.biomaterials.2007.02.017. Epub 2007 Mar 13.

DOI:10.1016/j.biomaterials.2007.02.017
PMID:17353047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2262162/
Abstract

Bioprosthetic heart valves (BHVs) derived from glutaraldehyde crosslinked porcine aortic valves are frequently used in heart valve replacement surgeries. However, BHVs have limited durability and fail either due to degeneration or calcification. Glycosaminoglycans (GAGs), one of the integral components of heart valve cuspal tissue, are not stabilized by conventional glutaraldehyde crosslinking. Previously we have shown that valvular GAGs could be chemically fixed with GAG-targeted chemistry. However, chemically stabilized GAGs were only partially stable to enzymatic degradation. In the present study an enzyme inhibitor was incorporated in the cusps to effectively prevent enzymatic degradation. Thus, neomycin trisulfate, a known hyaluronidase inhibitor, was incorporated in cusps via 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide (EDC/NHS) chemistry followed by glutaraldehyde crosslinking (NEG). Controls included cusps crosslinked with either EDC/NHS followed by glutaraldehyde (ENG) or only with glutaraldehyde (GLUT). NEG group showed improved resistance to in vitro enzymatic degradation as compared to GLUT and ENG groups. All groups showed similar collagen stability, measured as a thermal denaturation temperature by differential scanning calorimetry (DSC). The cusps were implanted subdermally in rats to study in vivo degradation of GAGs. NEG group preserved significantly more GAGs than ENG and GLUT. NEG and ENG groups showed reduced calcification than GLUT.

摘要

源自戊二醛交联猪主动脉瓣的生物人工心脏瓣膜(BHVs)常用于心脏瓣膜置换手术。然而,BHVs的耐久性有限,会因退变或钙化而失效。糖胺聚糖(GAGs)是心脏瓣膜尖组织的重要组成部分之一,传统的戊二醛交联无法使其稳定。此前我们已表明,瓣膜GAGs可用靶向GAG的化学方法进行化学固定。然而,化学稳定的GAGs对酶降解仅部分稳定。在本研究中,将一种酶抑制剂掺入瓣膜尖以有效防止酶降解。因此,通过1-乙基-3-(3-二甲基氨基丙基)碳二亚胺/N-羟基琥珀酰亚胺(EDC/NHS)化学方法将已知的透明质酸酶抑制剂硫酸新霉素掺入瓣膜尖,随后进行戊二醛交联(NEG)。对照组包括用EDC/NHS随后戊二醛交联的瓣膜尖(ENG)或仅用戊二醛交联的瓣膜尖(GLUT)。与GLUT和ENG组相比,NEG组对体外酶降解的抵抗力有所提高。通过差示扫描量热法(DSC)以热变性温度衡量,所有组的胶原蛋白稳定性相似。将瓣膜尖皮下植入大鼠体内以研究GAGs的体内降解情况。NEG组保留的GAGs明显多于ENG组和GLUT组。NEG组和ENG组的钙化程度低于GLUT组。